We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3391:TSETSURUHA Holdings, Inc. Analysis

Data as of 2026-06-13 - not real-time

¥2,079.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Tsuruha Holdings is trading at ¥2,079, which sits just above its 20‑day SMA (¥2,016.7) but remains under the 50‑day (¥2,111.9) and 200‑day (¥2,453.1) averages, signaling a short‑term pullback within a longer‑term bearish backdrop. The RSI of 53 suggests neutral momentum, while the MACD histogram is positive (≈23) and the MACD line sits above its signal, offering a bullish technical signal despite the overall bearish trend direction. Volume has been declining and 30‑day volatility is high at over 38%, indicating a choppy trading environment. The stock’s beta of –0.57 points to an inverse correlation with the broader market, which can provide a defensive edge when equities are under pressure. Valuation metrics are attractive: a trailing PE of 14.4 is well below the industry average of 24.8, and a forward PE of 3.3 implies substantial earnings upside.
The DCF‑derived fair value of ¥2,087 is essentially in line with the current price, yet analyst consensus targets around ¥2,600‑2,650 imply a potential upside of roughly 25%. The dividend yield of 2.31% with a payout ratio near 35% appears sustainable given the company’s strong cash position (¥202 bn) despite a high debt‑to‑equity ratio. The market sentiment index reads “Extreme Greed” (89.9), which may be inflating short‑term buying pressure. With no revenue growth this year but a projected forward EPS jump from ¥144 to ¥625, the earnings trajectory is driven more by margin expansion and ancillary services than top‑line expansion. Overall, the blend of defensive valuation, modest dividend, and analyst‑driven upside supports a cautiously optimistic stance for investors willing to navigate the near‑term volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price hovering below the 50‑day SMA
  • decreasing volume and high volatility
  • bearish trend despite bullish MACD histogram

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • valuation gap versus industry PE
  • forward earnings expansion (PE 3.3)
  • analyst target upside of ~25%

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • sustainable dividend supported by strong cash flow
  • defensive negative beta profile
  • growth potential from ancillary services and wellness care

Key Metrics & Analysis

Financial Health

Profit Margin2.94%
P/E Ratio14.4
ROE7.55%
ROA3.53%
Debt/Equity23.28
P/B Ratio1.1
Op. Cash Flow¥84.6B
Free Cash Flow¥71.9B
Industry P/E24.8

Technical Analysis

TrendBearish
RSI53.4
Support¥1,889.00
Resistance¥2,147.00
MA 20¥2,016.70
MA 50¥2,111.91
MA 200¥2,453.08
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value¥2,087.46
Target Price¥2,596.67
Upside/Downside24.90%
GradeUndervalued
TypeBlend
Dividend Yield2.31%

Risk Assessment

Beta-0.57
Volatility38.34%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.